The patient with Alzheimer's disease

Quintessence International

Volumn 32, Issue 3, 2001, Pages 221-231

  Gitto, Christina A ^a   Moroni, Michael J ^a   Terezhalmy, Geza T ^b   Sandu, Satinderpal ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; CLASSIFICATION; DENTAL CARE; DENTAL SURGERY; DISEASE COURSE; FEMALE; HUMAN; MALE; MEDICAL ETHICS; METHODOLOGY; MOUTH DISEASE; MOUTH HYGIENE; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT CARE PLANNING; PERIODONTAL DISEASE; PSYCHOLOGICAL ASPECT; REVIEW; SELF CARE; TOOTH DISEASE; TOOTH PLAQUE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DENTAL CARE FOR DISABLED; DENTAL PLAQUE; DENTAL RESTORATION, PERMANENT; DISEASE PROGRESSION; ETHICS, DENTAL; FEMALE; HUMANS; MALE; MOUTH DISEASES; ORAL HYGIENE; PATIENT CARE PLANNING; PATIENT CARE TEAM; PERIODONTAL DISEASES; SELF CARE; TOOTH DISEASES;

EID: 0035278868     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer's disease in a community of older persons. J Am Med Assoc 1989;262: 2552-2556.
2. Hoffman et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-154.
3. Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, et al. The APOE-epsilon4-allele and the risk of Alzheimer's disease among African Americans, whites, and hispanics. J Am Med Assoc 1998;279:751-755.
4. Reiman EM, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon-4 allelefor apolipoprotein E. N Engl J Med 1996;334:752-758.
5. Geula et al. Aging renders the brain vulnerable to ameloid Beta-protein neurotoxicity. Nature Medicine 1998;4: 827-831.
6. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-1455.
7. Heyman A, Wilkinson W, et al. Alzheimer's disease: Genetic aspects and associated clinical disorders. Ann Neurol 1983;14:507-515.
8. Evans DA. Estimated prevalence of Alzheimer's disease in the United States. Milbank Q 1990;68:267-289.
9. Geldmacher DS, Whitehouse PJ. Evaluation of dementia. N Engl J Med 1996;335:330-336.
10. Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer Disease and related disorders. J Am Med Assoc 1997;278:1363-1371.
11. Geldmacher DS. Office diagnosis and management of Alzheimer's Disease. Mediguide to Geriatric Neurology 1998;2(4):1-8.
12. Rogers SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US Multicenter Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. Dementia 7:293-303.
13. Cummings JL, et al. Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Neurology 1998;50; 1214-1221.
14. Morris JC, et al. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease. Neurology 1998;50:1222-1230.
15. Knopman DS. Metrifonate for Alzheimer's disease: Is the next cholinesterase inhibitor better? Neurology 1998;50: 1203-1205.
16. Xu H et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 1998;4: 447-451.
17. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med 1996;156:2213-2217.
18. Stewart WF et al. Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997;48:626-632.
19. Sano M et al. A controlled trial of selegiline, alpha-tocophenol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336:1216-1222.
20. Drachman DA, Leber P. Treatment of Alzheimer's disease - searching for a breakthrough, settling for less. N Engl J Med 1997;336:1245-1247.
21. Tariot PN. Treatment strategies in Alzheimer's Disease. Mediguide to Geriatric Neurology 1997;1(6):1-8.
22. Kleijnen J, Knipschild P. Ginkgo biloba. Lancet 1992;340: 1136-1139.
23. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. J Am Med Assoc 1997;278:1327-1332.
24. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996;46:1775-1776.
25. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997; 336:1108.
26. Mathews MK, Jr. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 1998;50:1933-1934.
27. Devanand DP, et al. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry 1998;155:1512-1520.
28. Woerner MG et al. Prospective study of tardive dyskinesia in the elderly: Rates and risk factors. Am J Psychiatry 1998; 155:1521-1528.
29. Henry RG, Wekstein DR. Providing dental care for patients diagnosed with Alzheimer's disease. Dent Clin North Am 1997;41:915-944.
30. Ship JA, Puckett SA. Longitudinal study on the oral health in subjects with Alzheimer's disease. J Am Geriatr Soc 1994;42:57-63.
31. Ship JA. Oral health of patients with Alzheimer's Disease. J Am Dent Assoc 1992;123:53-58.
32. Jones J, Lavelle N, et al. Caries incidence in patients with dementia. Gerondontology 1993;10:76-82.
33. Wittle JG, Sarll DW, Grant AA, Worthington HV. The dental health of the elderly mentally ill: A preliminary report. Br Dent J 1987;162:381-383.
34. Ship JA, DeCarli C, Friedland RP, Baum BJ. Diminished sub-mandibular salivary flow in dementia of the Alzheimer type. J of Gerontol: Medical Sciences 1990;42(2):M61-M66.
35. Niessen LC, Jones JA, Zocchi M, Gurian B. Dental care for the patient with Alzheimer's disease. J Am Dent Assoc 1985;110:207-209.
36. Carr-Hosie MA. Treatment considerations for the dental professional for patients with Alzheimer's Disease. Ohio Dent J 1993;Winter:36-42.
37. ADA Oral Health Care Guidelines: Patients with physical and mental disabilities. Chicago: American Dental Association, 1991.
38. Casada JP, Casada DB. Guidelines for dental care for the patient with Alzheimer's Disease. J Gt Houst Dent Soc 1990;Feb 3-5.
39. Boccia A. Alzheimer's Disease and the dental patient: Recognizing and dealing with dementia. Ont Dent 1992; April:16-18.
40. Henry RG. Alzheimer's disease and cognitively impaired elderly; providing dental care. CDA J 1999;27:709-717.
41. Navazesh M, Mulligan R. Systemic dissemination as a result of oral infection in individuals 50 years of age and older. Spec Care Dent 1995;15:11-19.
42. Barrett-Connor E, et al. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 1996; 44:1147-1152.
43. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients or the clinician. J Psychiatr Res 1975;12:189-198.
44. Park KK, Matis BA, Christen AG. Choosing an effective toothbrush. Clin Prev Dent 1985;7:5-9.
45. Mandel ID. The plaque fighters. J Am Dent Assoc 1993;124: 71-73.
46. Youngblood JJ, Killoy W, Love JW, Drisko C. Effectiveness of a new home plaque removal instrument in removing sub-gingival and interproximal plaque: A preliminary in vivo report. Compend Contin Educ Dent 1985;6:S128-S132.
47. Baab DA, Johnson RH. The effect of new electric toothbrush on supragingival plaque and gingivitis. J Periodontol 1989;60:336-341.
48. Killoy WJ, Love JW, Love J, Fedi PF Jr, Tira DE. The effectiveness of a counter-rotary action-powered toothbrush and conventional toothbrush on plaque removal and gingival bleeding. A short-term study. J Periodontol 1989;60: 473-477.
49. Wilcoxon DB, Ackerman RJ Jr, Kolloy WS, Love JW, Sakumura JS, Tira DE. The effectiveness of a counter-rotational action power toothbrush on plaque control in orthodontic patients. Am J Orthod Dentofacial Orthop 1991; 99:7-14.
50. Wilson S, Levine D, Dequincy G, Killoy W. Effects of two toothbrushes on plaque, gingivitis, gingival abrasion and recession: A one-year longitudinal study. J Dent Res 1993; 72:333.
51. Yukna RA, Shaklee RL. Interproximal vs midradicular effects of a counter-rotational powered brush during supportive periodontal therapy. Compend Contin Educ Dent 1993;14(suppl, 16):s580-s586.
52. Love JW, Drisko CL, Killoy WJ, Tira DE, Love JD. Clinical assessment of the INTERPLAK powered toothbrush vs a conventional brush plus floss. Compend Contin Educ Dent 1993;14(suppl, 16):s87-s98.
53. Blahunt P. A clinical trial of the Interplak powered toothbrush in a geriatric population. Compend Contin Educ Dent 1993;14(suppl, 16):s606-s610.
54. Terezhalmy GT, Gagliardi VB, Rybicki LA, Kauffman MJ. Clinical evaluation of the efficacy and safety of the Ultra-Sonex ultrasonic toothbrush: A 30-day study. Compend Contin Educ Dent 1994;XV:866-874.
55. Terezhalmy GT, Iffland H, Jelepis C, Waskowski J. Clinical evaluation of the effect of an ultrasonic toothbrush on plaque, gingivitis, and gingival bleeding: A six-month study. J Prosthet Dent 1995;73:97-103.
56. Whitmyer CC, Terezhalmy GT, Miller DL, Hujer ME. Clinical evaluation of the efficacy and safety of an ultrasonic toothbrush system in an elderly patient population. Geriatr Nurs 1998;19:29-33.
57. Shinada K, Hashizume LN, Teraoka K, Kurosaki N. Effect of ultrasonic toothbrush on Streptococcus mutans. The Japanese Journal of Conservative Dentistry 1999;42: 410-417.
58. Matear DW, Clarke D. Considerations for the use of oral sedation in the institutionalized geriatric patient during dental interventions: A review of the literature. Spec Care Dent 1999;19:56-63.
59. Saxe SR, Wekstein MW, Kryscio RJ, Henry RG, et al. Alzheimer's disease, dental amalgam and mercury. J Am Dent Assoc 1999;130:191-199.